1) American Academy of Child and Adolescent Psychiatry:Practice parameter for the use of stimulant medication in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 41 (Supple 2):S26-S49, 2002
2) American Academy of Child and Adolescent Psychiatry:Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 46:1503-1526, 2002
3) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, 5th ed. American Psychiatric Association, Arlington, 2013
4) Gleason M, Egger H, Emsli G, et al:Psychopharmacological treatment for very young children:Contexts and guidelines. J Am Acad Child Adolesc Psychiatry 46:1532-1572, 2007
5) Greenhill L, Kollins S, Abikoff H, et al:Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 45:1284-1293, 2006
6) MTA Cooperative Group:National Institute of Mental Health Multimodal Treatment Study of ADHD Follow-up:Changes in effectiveness and growth after the end of treatment. Pediatrics 113:762-769, 2004
7) Shaw P, Eckstrand K, Sharp W, et al:Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci USA 104:19649-19654, 2007
8) Shaw P, Malek M, Watson B, et al:Development of cortical surface area and gyrification in attention-deficit/hyperactivity disorder. Biol Psychiatry 72:191-197, 2012
9) Vitiello B:Pediatric psychopharmacology and the interaction between drugs and the developing brain. Can J Psychiatry 43:582-584, 1998